%PDF-1.4
%
41 0 obj
<>
endobj
38 0 obj
<>
endobj
97 0 obj
<>stream
Acrobat Distiller 4.05 for Macintosh
2004-05-11T16:57:58Z
2024-03-29T08:21:40-07:00
QuarkXPressª 4.11: AdobePS 8.8.0 (301)
2024-03-29T08:21:40-07:00
application/pdf
Heather
2003-142.june
uuid:4bbc9c48-1dd2-11b2-0a00-5208278d5b00
uuid:4bbc9c4a-1dd2-11b2-0a00-1e0000000000
endstream
endobj
27 0 obj
<>
endobj
28 0 obj
<>
endobj
42 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 17 0 R/Type/Page>>
endobj
1 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Thumb 19 0 R/Type/Page>>
endobj
14 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 21 0 R/Type/Page>>
endobj
107 0 obj
[111 0 R]
endobj
108 0 obj
<>stream
q
0 0 612 792 re
W n
BT
0.85091 0.85091 0.85091 rg
/T1_0 19 Tf
0.6303 0.7762 -0.7762 0.6303 16.7778 46.0632 Tm
(Personal non-commercial use only. The Journal of Rheumatology. Copyright\
\251 2004. All rights reserved)Tj
ET
Q
1 g
/GS0 gs
0 792 m
0 792 l
f
q
-1 793 614 -794 re
W n
q
0 792.03 612 -792 re
W n
0 0 0 1 K
/GS1 gs
54 54 m
558 54 l
S
BT
0 0 0 1 k
/T1_1 1 Tf
-0.00011 Tc 0.02499 Tw 8 0 0 8 424.3613 35.9844 Tm
(The Journal of Rheumatology 2004; 31:6)Tj
0 Tc 0 Tw -46.2952 -0.0313 Td
(1224)Tj
ET
0 0 0 0 k
/GS0 gs
109.25 59.09 396.47 -10.83 re
f*
0.5 w
109.25 59.09 396.47 -10.83 re
S
BT
0 0 0 1 k
/GS1 gs
/T1_2 1 Tf
-0.00011 Tc -0.0164 Tw 10 0 0 10 54 713.1616 Tm
(and commonly our goals are modest: control of progression,)Tj
0.23779 Tw 0 -1.2 TD
(treatment of complications, etc. Hence, chronic illnesses)Tj
0.0731 Tw T*
(become a part of the life of our patients. Uninvited guests,)Tj
0.0385 Tw T*
[(they slowly modify behavior)39.7 (, lifestyle, and physical aspect.)]TJ
0.02499 Tw T*
(How deep can they reach and how much can they modify? )Tj
0.0224 Tw 1.2 -1.2 Td
(In the clinical setting, the subjective point of view of the)Tj
-0.03419 Tw -1.2 -1.2 Td
(patient may become an uncomfortable and conceivably even)Tj
0.1591 Tw T*
[(annoying element. Sometimes it is dif)17.7 (ficult to know how)]TJ
0.2106 Tw T*
[(much weight to give to their complaints. )17.7 (The mind is a)]TJ
0.3439 Tw T*
[(private, hidden, internal, unequivocal subjective entity)64.8 (.)]TJ
0 Tc 0 Tw 6.5 0 0 6.5 290.7501 608.4615 Tm
(9)Tj
-0.00011 Tc 0.27251 Tw 10 0 0 10 54 593.1616 Tm
[(Sense of self is extremely important in a person\325)54.8 (s life.)]TJ
0.08411 Tw T*
(Losing it may be devastating: it can lead to serious conse-)Tj
0.0657 Tw T*
(quences, even suicide. It is simple to imagine this scenario)Tj
-0.02271 Tw T*
[(in a person who has been mutilated. However)39.7 (, a careful look)]TJ
-0.0307 Tw T*
(reveals that patients with subtle physical modifications, with)Tj
0.0016 Tw T*
(common diseases, live through similar experiences, perhaps)Tj
0.02499 Tw T*
(to a lesser degree, all the time.)Tj
0.0024 Tc 0.3725 Tw 1.2 -1.2 Td
(What must we do, as physicians, concerning these)Tj
-0.00011 Tc 0.2114 Tw -1.2 -1.2 Td
[(issues? Unfortunately)64.8 (, the magic of the patient-physician)]TJ
0.2094 Tw T*
(relationship is menaced and many doctors treat only the)Tj
0.2592 Tw T*
(disease and leave its psychological consequences to the)Tj
0.03931 Tw T*
[(patients to deal with. )54.8 (Although there are no straightforward)]TJ
0.0146 Tw T*
(answers to these issues, we should at least think about them)Tj
0.2924 Tw 26.4 26.4 Td
(and keep in mind that sometimes patients worry about)Tj
0.0031 Tw T*
[(dif)17.7 (ferent things, about aspects of their disease that may pass)]TJ
0.02499 Tw T*
(totally unnoticed by us. )Tj
/T1_3 1 Tf
0 Tw 0 -2.4 TD
(REFERENCES)Tj
/T1_2 1 Tf
0.02499 Tw 8 0 0 8 325 655.1616 Tm
[(1.)-875.1 (Block JA, Sequeira )17.7 (W)91.8 (. Raynaud\325)54.8 (s phenomenon. Lancet)]TJ
0 Tc 0 Tw 1.675 -1.25 Td
(2001;357:2042-8.)Tj
-0.00011 Tc 0.02499 Tw -1.675 -1.25 Td
[(2.)-875.1 (W)39.8 (igley FM, Flavahan NA. Raynaud\325)54.8 (s phenomenon. Rheum Dis)]TJ
0 Tc 1.675 -1.25 Td
[(Clin N )54.8 (Am 1996;22:765-81.)]TJ
-0.00011 Tc -1.675 -1.25 Td
[(3.)-875.1 (T)35 (urton EPL, Kent PJ, Kester RC. )17.7 (The aetiology of Raynaud\325)54.8 (s)]TJ
1.675 -1.25 Td
[(phenomenon. Cardiovasc Sur)17.7 (g 1998;6:431-40.)]TJ
-1.675 -1.25 Td
[(4.)-875.1 (Belch JJF)79.7 (, Ho M. Pharmacotherapy of Raynaud\325)54.8 (s phenomenon.)]TJ
0 Tc 1.675 -1.25 Td
(Drugs 1996;52:682-5.)Tj
-0.00011 Tc -1.675 -1.25 Td
[(5.)-875.1 (Y)99.8 (ell JA, Mbuagbaw J, Bur)17.7 (ge SM. Cutaneous manifestations of)]TJ
1.675 -1.25 Td
(systemic lupus erythematosus. Br J Dermatol 1996;35:355-62.)Tj
-1.675 -1.25 Td
[(6.)-875.1 (Cardinali C, Caproni M, Bernacchi E, )54.8 (Amato L, Fabal P)110.7 (.)-0.1 ( )17.7 (The )]TJ
1.675 -1.25 Td
[(spectrum of cutaneous manifestations in lupus erythematosus. )17.7 (The)]TJ
0 -1.25 TD
(Italian experience. Lupus 2000;9:417-23.)Tj
-1.675 -1.25 Td
[(7.)-875.1 (Kapadia N. Cutaneous manifestations of systemic lupus )]TJ
1.675 -1.25 Td
(erythematosus: study from Lahore, Pakistan. Int J Dermatol)Tj
0 Tc 0 Tw T*
(1996;35:408-9.)Tj
-0.00011 Tc 0.02499 Tw -1.675 -1.25 Td
[(8.)-875.1 (V)128.9 (ormittag )17.7 (W)91.8 (,)-0.1 ( )17.7 (W)79.9 (eninger M, Scherak O, Kolarz G. Dermatoglyphics)]TJ
1.675 -1.25 Td
(and systemic lupus erythematosus. Scand J Rheumatol)Tj
0 Tc 0 Tw T*
(1981;10:296-8.)Tj
-0.00011 Tc 0.02499 Tw -1.675 -1.25 Td
[(9.)-875.1 (Damasio )54.8 (AR. How the brain creates the mind. Scientific )54.8 (Am)]TJ
0 Tc 0 Tw 1.675 -1.25 Td
(1999;280:74-9.)Tj
ET
Q
Q
q
0 0 612 792 re
W n
BT
0 0 0 rg
/GS2 gs
/T1_4 8 Tf
119.868 51 Td
(Personal, non-commercial use only. The Journal of Rheumatology. Copyri\
ght \251 2004. All rights reserved.)Tj
ET
Q
BT
0 g
/GS2 gs
/T1_5 1 Tf
10 0 0 10 540 17 Tm
( )Tj
0 0.48627 0.77255 rg
/GS2 gs
-7.22298 0 Td
(www.jrheum.org)Tj
0 g
/GS2 gs
-16.72996 0 Td
(Downloaded on March 29, 2024 from )Tj
ET
endstream
endobj
21 0 obj
<>stream
8;Z]";%g_g$q.Z+"nt&=L!Tf#8SiNkp3j@WH?gBgY9PHDuVF,T?8[p>)Brd'4h8,TJX0"N1?^Y7!A!bbX
kgq[1@q3]m.?tLF9]b:o>;n=;.Jn#R4G6>YZ=NcgGM.hH41B8t.[]L1O7sEqeO<5U
f^ueRhQsU:^E'?,FVt>r3geZ"o>"WboBu\Ob(2)hePXQ%/*"Pa+bUCn#U+j4EX1nN
l/jl]+S(q[Y>=t5Oq5(Sf3e+d!3/TmQi~>
endstream
endobj
25 0 obj
[/Indexed/DeviceRGB 255 24 0 R]
endobj
24 0 obj
<>stream
J,g]g+e/h_!_gCtO=0f)$P%cIi8Zdfc5&3j_8$7g.@L`YKUJNGBP\poR=_;Dl'P(T
(7Boo^^S:71(MN]ZQX/+Cbu.lK"p74pe1T%s.DY%&\1TdJhr54.M9au6>79n6`Q:4
PbLSZTLEE(8E@'*1mg_*eTnN*;*'V3+gm-EEetX%;Bo$ur2ss*N`.-!.kG_q6GDD'
dKoL!8Ka#EV,@V!\j8ZFbp6EE<9cn=N6j0nf;(&;QU6bUD')c@\
9-d\DA=cZ0Q>gIM$$;cd2O@&a;X,Nn_aP(]I1aRc(K1^ue>
gF/(+GaKo$qneLWDrQ#;5\S(\$q'4Q,85`-8;S(=Z"WSBOV*FM)4,?B],R
endstream
endobj
90 0 obj
<>
endobj
45 0 obj
<>
endobj
47 0 obj
<>
endobj
52 0 obj
<>
endobj
83 0 obj
<>
endobj
102 0 obj
<>
endobj
53 0 obj
<>
endobj
78 0 obj
<>stream
HLS{PTUeU]!i>ZFyCQ$)GC`e,Z*"">"|9kl5N};cw?s3ߜ~
hLK]9m옑bR&(cB!|,E?e55p#gtf^SFcL1nTH;UNqcB0&